Denver-based DaVita announced Wednesday it is collaborating with the Yangpu District of Shanghai, China, with the aim of improving dialysis patients’ quality of life while controlling or minimizing medical expenses.
DaVita said that with the support of the district government and approval of the health bureau, it and Shanghai Yangpu Antu Hospital are establishing a renal-dialysis-technology collaboration base at the 400-bed hospital.
DaVita will provide consultation services to the public hospital on advanced management processes for its renal outpatient visits and dialysis treatments.
In addition, DaVita and the hospital will upgrade clinic technology and expand the number of dialysis stations.
“In support of Chinese health care reform, DaVita’s objective is to pilot a sustainable, cost-effective and high quality renal care and dialysis network with Antu Hospital and within the Yangpu District,” said Atul Mathur, president of DaVita’s Asia-Pacific operations.
Mathur said in a statement that DaVita anticipates the collaboration will serve as a model for other communities in China.
Last year, DaVita entered China with a joint-venture deal with 3sBio Inc., a leading Chinese biotechnology developer of biopharmaceuticals, providing dialysis treatments in northeastern China.
Howard Pankratz: 303-954-1939, hpankratz@denverpost.com or
